Yen-Der Li
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Chien‐Fu Hung (4 shared papers)Louise Ferrall (3 shared papers)T.‐C. Wu (3 shared papers)Jun-Han Su (2 shared papers)Benjamin L. Ebert (5 shared papers)Hsin‐Che Huang (1 shared paper)Timothy En Haw Chan (1 shared paper)Justine C. Rutter (2 shared papers)
- Journals
- Journal of Biomedical Science (2 papers)iScience (1 paper)Journal of the American Chemical Society (1 paper)Nature Chemical Biology (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Yen-Der Li
15 papers receiving 1.1k citations
Yen-Der Li's Hit Papers
Peers
Comparison fields: 5 of 109
- Infectious Diseases 292
- Health 87
- Modeling and Simulation 43
- Oncology 224
- Molecular Biology 612
Countries citing papers authored by Yen-Der Li
This map shows the geographic impact of Yen-Der Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen-Der Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen-Der Li more than expected).
Fields of papers citing papers by Yen-Der Li
This network shows the impact of papers produced by Yen-Der Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen-Der Li. The network helps show where Yen-Der Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yen-Der Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K Hit paper breakdown → | 2020 | 347 |
| 2 | 2020 | 317 | |
| 3 | COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection Hit paper breakdown → | 2022 | 142 |
| 4 | 2024 | 60 | |
| 5 | 2021 | 47 | |
| 6 | 2023 | 46 | |
| 7 | 2023 | 46 | |
| 8 | 2024 | 45 | |
| 9 | 2020 | 29 | |
| 10 | 2024 | 18 | |
| 11 | 2021 | 16 | |
| 12 | 2014 | 12 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 4 |
About Yen-Der Li
Yen-Der Li is a scholar working on Infectious Diseases, Hematology, Oncology, Molecular Biology and Physiology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Influenza Virus Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (292 citations), Health (87 citations), Modeling and Simulation (43 citations), Oncology (224 citations) and Molecular Biology (612 citations). Yen-Der Li has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Chien‐Fu Hung, Louise Ferrall, T.‐C. Wu, Jun-Han Su, Benjamin L. Ebert, Hsin‐Che Huang, Timothy En Haw Chan, Justine C. Rutter, Hojong Yoon and Eric S. Fischer. Their work appears in journals such as Journal of Biomedical Science, iScience, Journal of the American Chemical Society, Nature Chemical Biology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.